Return to search

Protalix BioTherapeutics attracts $43.7m

Protalix BioTherapeutics Inc, a biopharmaceutical company, has raised $43.7 million in funding.

Protalix BioTherapeutics Inc, a biopharmaceutical company, has raised $43.7 million in funding. The investors included Psagot Investment House, More Investment House, Highbridge Capital, UBS O’Connor, Rosalind Capital and Alrov Properties. Rosario Capital and Houlihan Lokey were financial advisors on the private placement.

Source: Press Release